Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 24
237
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Anti-inflammatory xenicane-type diterpenoid from the intertidal brown seaweed Sargassum ilicifolium

&
Pages 5699-5709 | Received 30 May 2020, Accepted 04 Sep 2020, Published online: 30 Sep 2020

References

  • Abad MJ, Bedoya LM, Bermejo P. 2008. Natural marine anti-inflammatory products. Mini Rev Med Chem. 8(8):740–754.
  • Ajay A, Walters WP, Murcko MA. 1998. Can we learn to distinguish between “drug-like” and “nondrug-like” molecules? J Med Chem. 41(18):3314–3324.
  • Antony T, Chakraborty K. 2020. First report of antioxidant abeo-labdane type diterpenoid from intertidal red seaweed Gracilaria salicornia with 5-lipoxygenase inhibitory potential. Nat Prod Res. 34(10):1409–1416.
  • Barbosa JP, Fleury BG, da Gama BAP, Teixeira VL, Pereira RC. 2007. Natural products as antifoulantsin the Brazilian brown alga Dictyota pfaffi (phaeophyta, dictyptales). Biochem Syst Ecol. 35(8):549–553.
  • Baylac S, Racine P. 2003. Inhibition of 5-lipoxygenase by essential oils and other natural fragment extracts. Int J Aromather. 13(2-3):138–142.
  • Betschart L, Altmann KH. 2015. Xenicane natural products: biological activity and total synthesis. Curr Pharm Des. 21(38):5467–5488.
  • Chakraborty K, Dhara S. 2019. First report of substituted 2H-pyranoids from brown seaweed Turbinaria conoides with antioxidant and anti-inflammatory activities. Nat Prod Res. E-publication ahead of print Mar 5 2019:1-11. doi: https://doi.org/10.1080/14786419.2019.1578761.
  • Chakraborty K, Raola VK. 2018. In vitro bioactive analysis and antioxidant activity of two species of seaweeds from the Gulf of Mannar. Nat Prod Res. 32(22):2729–2734.
  • Daina A, Michielin O, Zoete V. 2017. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 7:42717.
  • Gilbert NC, Rui Z, Neau DB, Waight MT, Bartlett SG, Boeglin WE, Brash AR, Newcomer ME. 2012. Conversion of human 5-lipoxygenase to a 15-lipoxygenase by a point mutation to mimic phosphorylation at serine-663. FASEB J. 26(8):3222–3229.
  • Huber T, Weisheit L, Magauer T. 2015. Synthesis of xenia diterpenoids and related metabolites isolated from marine organisms. Beilstein J Org Chem. 11:2521–2539.
  • Laneuville O, Breuer DK, Dewitt DL, Hla T, Funck CD, Smith WL. 1994. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther. 271(2):927–934.
  • Larsen LN, Dahl E, Bremer J. 1996. Peroxidative oxidation of leuco-dichlorofluorescein by prostaglandin H synthase in prostaglandin biosynthesis from polyunsaturated fatty acids. Biochim Biophys Acta. 1299(1):47–53.
  • Lipinski C, Hopkins A. 2004. Navigating chemical space for biology and medicine. Nature. 432(7019):855–861.
  • Makkar F, Chakraborty K. 2018a. Previously undescribed antioxidative azocinyl morpholinone alkaloid from red seaweed Gracilaria opuntia with anti-cyclooxygenase and lipoxygenase properties. Nat Prod Res. 32(10):1150–1160.
  • Makkar F, Chakraborty K. 2018b. Highly oxygenated antioxidative 2H-chromen derivative from the red seaweed Gracilaria opuntia with pro-inflammatory cyclooxygenase and lipoxygenase inhibitory properties. Nat Prod Res. 32(23):2756–2765.
  • Maneesh A, Chakraborty K. 2017. Previously undescribed fridooleanenes and oxygenated labdanes from the brown seaweed Sargassum wightii and their protein tyrosine phosphatase-1B inhibitory activity. Phytochemistry. 144:19–32.
  • Martel-Pelletier J, Lajeunesse D, Reboul P, Pelletier JP. 2003. Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs. Ann Rheum Dis. 62(6):501–509.
  • Mattio L, Payri CE, Verlaque M. 2009. Taxonomic revision and geographic distribution of the subgenus Sargassum (Fucales, Phaeophyceae) in the Western and Central Pacific Islands based on morphological and molecular analyses. J Phycol. 45(5):1213–1227.
  • Meirer K, Steinhilber D, Proschak E. 2014. Inhibitors of the arachidonic acid cascade: interfering with multiple pathways. Basic Clin Pharmacol Toxicol. 114(1):83–91.
  • Montanari F, Ecker GF. 2015. Prediction of drug-ABC-transporter interaction-Recent advances and future challenges. Adv Drug Deliv Rev. 86:17–26.
  • Siamopoulou P, Bimplakis A, Iliopoulou D, Vagias C, Cos P, Vanden Berghe D, Roussis V. 2004. Diterpenes from the brown algae Dictyota dichotoma and Dictyota linearis. Phytochemistry. 65(14):2025–2030.
  • Sprangler RS. 1996. COX-2 activity can reduce the level of toxicity for a given NSAID but may not be sufficient to overcome toxicities resulting from other mechanisms. Semin Arthritis Rheum. 26:436–447.
  • Tanaka J, Higa T. 1984. Hydroxydictyodial, a new antifeedant diterpene from the brown alga Dictyota spinulosa. Chem Lett. 13(2):231–232.
  • Tanaka K, Taino S, Haraguchi H, Prendergast G, Hiraoka M. 2012. Warming off southwestern Japan linked to distributional shifts of subtidal canopy-forming seaweeds. Ecol Evol. 2(11):2854–2865.
  • Viano Y, Bonhomme D, Camps M, Briand J-F, Ortalo-Magné A, Blache Y, Piovetti L, Culioli G. 2009. Diterpenoids from the Mediterranean brown alga Dictyota sp. evaluated as antifouling substances against a marine bacterial biofilm. J Nat Prod. 72(7):1299–1304.
  • Wojdylo A, Oszmianski J, Czemerys R. 2007. Antioxidant activity and phenolic compounds in 32 selected herbs. Food Chem. 105(3):940–949.
  • Yende S R, Harle U N, Chaugule B B. 2014. Therapeutic potential and health benefits of Sargassum species. Pharmacogn Rev. 8(15):1–7. doi:https://doi.org/10.4103/0973-7847.125514.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.